|
1
|
Demuth T and Berens ME: Molecular
mechanisms of glioma cell migration and invasion. J Neurooncol.
70:217–228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu N, Zhao XZ, Liu M, Liu H, Yao W, Zhang
Y, Cao S and Lin X: Role of microRNA-26b in glioma development and
its mediated regulation on EphA2. PLoS One. 6:e162642011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tanase C, Albulescu R, Codrici E, Popescu
ID, Mihai S, Enciu AM, Cruceru ML, Popa AC, Neagu AI, Necula LG, et
al: Circulating biomarker panels for targeted therapy in brain
tumors. Future Oncol. 11:511–524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cruceru ML, Enciu AM, Popa AC, Albulescu
R, Neagu M, Tanase CP and Constantinescu SN: Signal transduction
molecule patterns indicating potential glioblastoma therapy
approaches. Onco Targets Ther. 6:1737–1749. 2013.PubMed/NCBI
|
|
6
|
Song Y, Mu L, Han X, Li Q, Dong B, Li H
and Liu X: MicroRNA-9 inhibits vasculogenic mimicry of glioma cell
lines by suppressing Stathmin expression. J Neurooncol.
115:381–390. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang M, Ke Y, Sun X, Yu L, Yang Z, Zhang
Y, Du M, Wang J, Liu X and Huang S: Mammalian target of rapamycin
signaling is involved in the vasculogenic mimicry of glioma via
hypoxia-inducible factor-1α. Oncol Rep. 32:1973–1980. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mosch B, Pietzsch D and Pietzsch J:
Irradiation affects cellular properties and Eph receptor expression
in human melanoma cells. Cell Adh Migr. 6:113–125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lytle JR, Yario TA and Steitz JA: Target
mRNAs are repressed as efficiently by microRNA-binding sites in the
5′ UTR as in the 3′ UTR. Proc Natl Acad Sci USA. 104:9667–9672.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bouyssou JM, Manier S, Huynh D, Issa S,
Roccaro AM and Ghobrial IM: Regulation of microRNAs in cancer
metastasis. Biochim Biophys Acta. 1845:255–265. 2014.PubMed/NCBI
|
|
11
|
Bandres E, Agirre X, Bitarte N, Ramirez N,
Zarate R, Roman-Gomez J, Prosper F and Garcia-Foncillas J:
Epigenetic regulation of microRNA expression in colorectal cancer.
Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, Wang X, Ruan A, Han W, Zhao Y, Lu
X, Xiao P, Shi H, Wang R, Chen L, et al: miR-141 is a key regulator
of renal cell carcinoma proliferation and metastasis by controlling
EphA2 expression. Clin Cancer Res. 20:2617–2630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shimono Y, Zabala M, Cho RW, Lobo N,
Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, et al:
Downregulation of miRNA-200c links breast cancer stem cells with
normal stem cells. Cell. 138:592–603. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mateescu B, Batista L, Cardon M, Gruosso
T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P,
Sastre-Garau X and Mechta-Grigoriou F: miR-141 and miR-200a act on
ovarian tumorigenesis by controlling oxidative stress response. Nat
Med. 17:1627–1635. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schickel R, Park SM, Murmann AE and Peter
ME: miR-200c regulates induction of apoptosis through CD95 by
targeting FAP-1. Mol Cell. 38:908–915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hatano M, Eguchi J, Tatsumi T, Kuwashima
N, Dusak JE, Kinch MS, Pollack IF, Hamilton RL, Storkus WJ and
Okada H: EphA2 as a glioma-associated antigen: A novel target for
glioma vaccines. Neoplasi. 7:717–722. 2005. View Article : Google Scholar
|
|
17
|
Yang L, Zhao J, Zhou G, Wang Y, Li L, Yuan
H, Nan X, Guan L and Pei X: The 9L(LUC)/Wistar rat glioma model is
not suitable for immunotherapy. Neural Regen Res. 7:1406–1411.
2012.PubMed/NCBI
|
|
18
|
Li XY, Zhao Y, Sun MG, Shi JF, Ju RJ,
Zhang CX, Li XT, Zhao WY, Mu LM, Zeng F, et al: Multifunctional
liposomes loaded with paclitaxel and artemether for treatment of
invasive brain glioma. Biomaterials. 35:5591–5604. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao F, Zuo Z, Cai G, Kang S, Gao X and Li
T: miRecords: An integrated resource for microRNA-target
interactions. Nucleic Acids Res. 37:(Database Issue). D105–D110.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ogawa K, Pasqualini R, Lindberg RA, Kain
R, Freeman AL and Pasquale EB: The ephrin-A1 ligand and its
receptor, EphA2, are expressed during tumor neovascularization.
Oncogene. 19:6043–6052. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin Q, Li X and Cao P: EphA2 modulates
radiosensitive of hepatocellular carcinoma cells via
p38/mitogen-activated protein kinase-mediated signal pathways.
Kaohsiung J Med Sci. 31:510–517. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zelinski DP, Zantek ND, Stewart JC,
Irizarry AR and Kinch MS: EphA2 overexpression causes tumorigenesis
of mammary epithelial cells. Cancer Res. 61:2301–2306.
2001.PubMed/NCBI
|
|
23
|
Shao Z, Zhang WF, Chen XM and Shang ZJ:
Expression of EphA2 and VEGF in squamous cell carcinoma of the
tongue: Correlation with the angiogenesis and clinical outcome.
Oral Oncol. 44:1110–1117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brantley-Sieders DM, Fang WB, Hicks DJ,
Zhuang G, Shyr Y and Chen J: Impaired tumor microenvironment in
EphA2-deficient mice inhibits tumor angiogenesis and metastatic
progression. FASEB J. 19:1884–1886. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nat.
435:834–838. 2005. View Article : Google Scholar
|
|
26
|
Chen B, Huang T, Jiang J, Lv L, Li H and
Xia S: miR-141 suppresses proliferation and motility of gastric
cancer cells by targeting HDGF. Mol Cell Biochem. 388:211–218.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou X, Xia Y, Su J and Zhang G:
Down-regulation of miR-141 induced by helicobacter pylori promotes
the invasion of gastric cancer by targeting STAT4. Cell Physiol
Biochem. 33:1003–1012. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu L, Li Q, Xu D, Wang Q, An Y, Du Q,
Zhang J, Zhu Y and Miao Y: hsa-miR-141 downregulates TM4SF1 to
inhibit pancreatic cancer cell invasion and migration. Int J Oncol.
44:459–466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Neves R, Scheel C, Weinhold S, Honisch E,
Iwaniuk KM, Trompeter HI, Niederacher D, Wernet P, Santourlidis S
and Uhrberg M: Role of DNA methylation in miR-200c/141 cluster
silencing in invasive breast cancer cells. BMC Res Notes.
3:2192010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Y, Ding Y, Huang J, Wang S, Ni W, Guan
J, Li Q, Zhang Y, Ding Y, Chen B and Chen L: MiR-141 suppresses the
migration and invasion of HCC cells by targeting Tiam1. PLoS One.
9:e883932014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peng T, Zhang S, Li W, Fu S, Luan Y and
Zuo L: MicroRNA-141 inhibits glioma cells growth and metastasis by
targeting TGF-β2. Am J Transl Res. 8:3513–3521. 2016.PubMed/NCBI
|
|
32
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et
al: MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
El Hallani S, Boisselier B, Peglion F,
Rousseau A, Colin C, Idbaih A, Marie Y, Mokhtari K, Thomas JL,
Eichmann A, et al: A new alternative mechanism in glioblastoma
vascularization: Tubular vasculogenic mimicry. Brain. 133:973–982.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu XM, Zhang QP, Mu YG, Zhang XH, Sai K,
Pang JC, Ng HK and Chen ZP: Clinical significance of vasculogenic
mimicry in human gliomas. J Neurooncol. 105:173–179. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Folberg R, Hendrix MJ and Maniotis AJ:
Vasculogenic mimicry and tumor angiogenesis. Am J Pathol.
156:361–381. 2000. View Article : Google Scholar : PubMed/NCBI
|
